Literature DB >> 25641910

Country variations in depressive symptoms profile in Asian countries: Findings of the Research on Asia Psychotropic Prescription (REAP) studies.

Kok-Yoon Chee1, Adarsh Tripathi2, Ajit Avasthi3, Mian-Yoon Chong4, Yu-Tao Xiang5, Kang Sim6, Tian-Mei Si7, Shigenobu Kanba8, Yan-Ling He9, Min-Soo Lee10, Helen Fung-Kum Chiu11, Shu-Yu Yang12, Hironori Kuga8, Pichet Udormatn13, Roy A Kallivayalil14, Andi J Tanra15, Margarita Maramis16, Sandeep Grover3, Loi-Fei Chin17, Rahima Dahlan18, Mohd Fadzli Mohamad Isa19, Esther Gunaseli M Ebenezer20, Norhayati Nordin21, Winston W Shen22, Naotaka Shinfuku23, Chay-Hoon Tan24, Norman Sartorius25.   

Abstract

INTRODUCTION: This study was to assess differences in the symptom profile of depressive illness across various countries/territories in Asia. The study was a part of the Research on Asia Psychotropic Prescription project. The participating countries/territories include China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Singapore, Taiwan, and Thailand.
METHODS: The pattern of depressive symptoms in 1,400 subjects with depressive disorder from 42 psychiatric centers in 10 Asian countries/territories was assessed. We collected information on socio-demographic and clinical characteristics with a standardized protocol and data collection procedure.
RESULTS: The most common presentations of depressive symptoms were persistent sadness, loss of interest, and insomnia. Similar findings were found regardless of the region, country, or its income level. Patients with depressive disorder from high-income countries presented significantly more with vegetative symptom cluster (P < 0.05), while those from the upper middle-income countries had significantly more with both mood (P < 0.001) and cognitive symptom clusters (P < 0.01). In lower middle-income countries, patients with depressive symptoms had significantly less mood symptom cluster (P < 0.001) but significantly more cognitive symptom cluster (P < 0.05). DISCUSSION: This study demonstrates that in Asia, despite variations in the initial symptom reported by the patients, across different countries/territories, core depressive symptoms remain the same. Variations have been found in presentation of depressive symptoms with regards to the level of income of countries. Physical or vegetative symptoms were reported more by centers in higher income countries, while depressive cognition and suicidal thoughts/acts were more frequently reported from lower income countries.
© 2015 Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  Asian; income; region; transcultural psychiatry

Mesh:

Substances:

Year:  2015        PMID: 25641910     DOI: 10.1111/appy.12170

Source DB:  PubMed          Journal:  Asia Pac Psychiatry        ISSN: 1758-5864            Impact factor:   2.538


  3 in total

1.  Relationships between Sleep Problems and Psychiatric Comorbidities among China's Wenchuan Earthquake Survivors Remaining in Temporary Housing Camps.

Authors:  Suo Jiang; Zheng Yan; Pan Jing; Changjin Li; Tiansheng Zheng; Jincai He
Journal:  Front Psychol       Date:  2016-10-18

2.  Network analysis of the depressive symptom profiles in Asian patients with depressive disorders: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD).

Authors:  Seon-Cheol Park; Eun Young Jang; Yu-Tao Xiang; Shigenobu Kanba; Takahiro A Kato; Mian-Yoon Chong; Shih-Ku Lin; Shu-Yu Yang; Ajit Avasthi; Sandeep Grover; Roy A Kallivayalil; Pichet Udomratn; Kok Yoon Chee; Andi J Tanra; Chay-Hoon Tan; Kang Sim; Norman Sartorius; Yong Chon Park; Naotaka Shinfuku
Journal:  Psychiatry Clin Neurosci       Date:  2020-03-05       Impact factor: 5.188

3.  Effects of Psychological Distress and Coping Resources on Internet Gaming Disorder: Comparison between Chinese and Japanese University Students.

Authors:  Anise M S Wu; Mark H C Lai; Mengxuan Zhang; Masao Yogo; Shu M Yu; Sijie Mao; Juliet Honglei Chen
Journal:  Int J Environ Res Public Health       Date:  2022-03-03       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.